Results 251 to 260 of about 66,322 (262)

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

Lancet, The, 2010
Frederick J Raal, Santos Rd, Santos R, Dirk J Blom   +2 more
exaly  

The evolving landscape of tissue‐agnostic therapies in precision oncology

Ca-A Cancer Journal for Clinicians
Vivek Subbiah, Bettina Ryll, Razelle Kurzrock   +2 more
exaly  

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

Lancet, The, 2007
Jayesh Desai, Suzanne George, Thomas Force   +2 more
exaly  

Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

Cancer Cell, 2011
Wei Xu, Hui Yang, Ping Wang
exaly  

SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN

Ca-A Cancer Journal for Clinicians, 2005
exaly  

TIMP3 tissue inhibitor of metalloproteinase-3

1998
Shirley Ayad, Ray Boot-Handford, Martin J. Humphries, Karl E. Kadler, Adrian Shuttleworth   +4 more
openaire   +1 more source

TIMP2 tissue inhibitor of metalloproteinase-2

1998
S AYAD, R BOOTHANDFORD, M HUMPHRIES, K KADLER, A SHUTTLEWORTH   +4 more
openaire   +1 more source

TIMP4 tissue inhibitor of metalloproteinase-4

1998
Shirley Ayad, Ray Boot-Handford, Martin J. Humphries, Karl E. Kadler, Adrian Shuttleworth   +4 more
openaire   +1 more source

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

Nature Reviews Drug Discovery, 2010
exaly  

A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole

Nature Reviews Drug Discovery, 2003
exaly